Hikma's Advair Generic Gets Further Delayed Post author:Sam Post published:March 11, 2018 Post category:BioPharma Hikma Pharmaceuticals generic version of Advair has hit a stumbling block with the FDA. Source: BioSpace You Might Also Like Insmed Rockets as Lung Drug Wows in Late-Stage Study September 4, 2017 FDA Formally Rejects Aradigm's Linhaliq, Requests a New Phase III Trial for Reconsideration January 28, 2018 FDA Approves Sanofi's Admelog, the First Follow-On Insulin to Control Sugar at Mealtime December 11, 2017
FDA Formally Rejects Aradigm's Linhaliq, Requests a New Phase III Trial for Reconsideration January 28, 2018
FDA Approves Sanofi's Admelog, the First Follow-On Insulin to Control Sugar at Mealtime December 11, 2017
